Cargando…
5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
BACKGROUND/AIMS: 5-Aminosalicylic acid (ASA) causes intolerance reactions in some patients. This study was performed to examine the prognosis of patients with ulcerative colitis (UC) and 5-ASA intolerance, and to evaluate the potential interaction between 5-ASA intolerance and the intestinal microbi...
Autores principales: | Mizuno, Shinta, Ono, Keiko, Mikami, Yohei, Naganuma, Makoto, Fukuda, Tomohiro, Minami, Kazuhiro, Masaoka, Tatsuhiro, Terada, Soichiro, Yoshida, Takeshi, Saigusa, Keiichiro, Hirahara, Norimichi, Miyata, Hiroaki, Suda, Wataru, Hattori, Masahira, Kanai, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000647/ https://www.ncbi.nlm.nih.gov/pubmed/32013315 http://dx.doi.org/10.5217/ir.2019.00084 |
Ejemplares similares
-
Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients
por: Mizuno, Shinta, et al.
Publicado: (2017) -
Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
por: Mikami, Yohei, et al.
Publicado: (2023) -
Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
por: Nanki, Kosaku, et al.
Publicado: (2018) -
Mucosal concentrations of N‐acetyl‐5‐aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine
por: Fukuda, Tomohiro, et al.
Publicado: (2020) -
The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry
por: Fukuda, Tomohiro, et al.
Publicado: (2017)